Creative Planning

Position in FOLD — AMICUS THERAPEUTICS, INC.

CIK 1540235 OVERLAND PARK, KS

Position in FOLD

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$6,203,006

+$472,760 QoQ

Shares Held

428,977

+6.6% QoQ

Ownership

0.137%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Mar 31, 2026

Creative Planning holds $360,319,340 across 212 Biotechnology names. FOLD ranks #13 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	109,524	$48,906,846
2	REGN	Regeneron Pharmaceuticals, Inc.	40,152	$31,023,040
3	INSM	INSMED Inc	72,200	$11,806,143
4	EXEL	Exelixis, Inc.	234,142	$10,042,350
5	BBIO	BridgeBio Pharma, Inc.	119,661	$8,886,025
6	PCVX	Vaxcyte, Inc.	140,177	$8,145,685
7	ALNY	Alnylam Pharmaceuticals, Inc.	24,122	$7,981,245
8	INCY	Incyte Corp	80,874	$7,611,860

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,203,006	428,977	+6.6%	Shares	Defined	2026-05-12
2025-12-31	$5,730,246	402,405	+5.6%	Shares	Sole	2026-02-17
2025-09-30	$3,002,460	381,023	+76.2%	Shares	Sole	2025-11-14
2025-06-30	$1,239,278	216,279	+507.1%	Shares	Defined	2025-08-08
2025-03-31	$290,716	35,627	-58.3%	Shares	Sole	2025-05-15
2024-12-31	$805,503	85,510	+61.8%	Shares	Defined	2025-02-14
2024-09-30	$564,491	52,855	+79.6%	Shares	Defined	2024-10-11
2024-06-30	$291,864	29,422	-13.3%	Shares	Defined	2024-08-15
2024-03-31	$399,624	33,924	+36.2%	Shares	Defined	2024-05-13
2023-12-31	$353,358	24,902	+46.9%	Shares	Defined	2024-02-14
2023-09-30	$206,111	16,950	+21.0%	Shares	Defined	2023-11-16
2023-06-30	$176,003	14,013	—	Shares	Sole	2023-07-21
No filing history on record for this holder in this stock.